Literature DB >> 24614220

2013 Dahl Lecture: American Heart Association council for high blood pressure research clarifying the physiology of endothelin.

David M Pollock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24614220      PMCID： PMC4127322          DOI： 10.1161/HYPERTENSIONAHA.114.02441

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  61 in total

1.  Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial.

Authors:  George L Bakris; Lars H Lindholm; Henry R Black; Henry Krum; Stuart Linas; Jennifer V Linseman; Sarah Arterburn; Philip Sager; Michael Weber
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

2.  Cooperative role of ETA and ETB receptors in mediating the diuretic response to intramedullary hyperosmotic NaCl infusion.

Authors:  Erika I Boesen; David M Pollock
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-15

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Role of endothelin receptor subtypes in the systemic and renal responses to endothelin-1 in humans.

Authors:  K A Kaasjager; S Shaw; H A Koomans; T J Rabelink
Journal:  J Am Soc Nephrol       Date:  1997-01       Impact factor: 10.121

5.  Sex differences in renal medullary endothelin receptor function in angiotensin II hypertensive rats.

Authors:  Wararat Kittikulsuth; Jennifer S Pollock; David M Pollock
Journal:  Hypertension       Date:  2011-06-06       Impact factor: 10.190

6.  Endothelin activation of reactive oxygen species mediates stress-induced pressor response in Dahl salt-sensitive prehypertensive rats.

Authors:  Gerard D'Angelo; Analia S Loria; David M Pollock; Jennifer S Pollock
Journal:  Hypertension       Date:  2010-06-14       Impact factor: 10.190

7.  Flow regulation of collecting duct endothelin-1 production.

Authors:  Brianna Lyon-Roberts; Kevin A Strait; Evan van Peursem; Wararat Kittikulsuth; Jennifer S Pollock; David M Pollock; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-22

8.  Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

Authors:  Donald E Kohan; Yili Pritchett; Mark Molitch; Shihua Wen; Tushar Garimella; Paul Audhya; Dennis L Andress
Journal:  J Am Soc Nephrol       Date:  2011-03-03       Impact factor: 10.121

9.  Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.

Authors:  Mohamed A Saleh; Erika I Boesen; Jennifer S Pollock; Virginia J Savin; David M Pollock
Journal:  Hypertension       Date:  2010-09-07       Impact factor: 10.190

10.  Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects.

Authors:  J Smolander; B Vogt; M Maillard; C Zweiacker; T Littke; T Hengelage; M Burnier
Journal:  Clin Pharmacol Ther       Date:  2009-03-11       Impact factor: 6.875
View more
  6 in total

1.  Endothelin type A receptor inhibition normalises intrarenal hypoxia in rats used as a model of type 1 diabetes by improving oxygen delivery.

Authors:  Stephanie Franzén; Fredrik Palm
Journal:  Diabetologia       Date:  2015-07-15       Impact factor: 10.122

Review 2.  Gut microbiota in hypertension.

Authors:  Pedro A Jose; Dominic Raj
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-09       Impact factor: 2.894

Review 3.  Cardiovascular Biomarkers: Lessons of the Past and Prospects for the Future.

Authors:  Farah Omran; Ioannis Kyrou; Faizel Osman; Ven Gee Lim; Harpal Singh Randeva; Kamaljit Chatha
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

Review 4.  Endothelin, sex, and pregnancy: unique considerations for blood pressure control in females.

Authors:  Ellen E Gillis; Jennifer M Sasser; Jennifer C Sullivan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-02       Impact factor: 3.619

5.  Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.

Authors:  Leopoldo Raij; Runxia Tian; Jenny S Wong; John C He; Kirk N Campbell
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-22

6.  Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway.

Authors:  Roberto Palacios-Ramírez; Raquel Hernanz; Angela Martín; José V Pérez-Girón; María T Barrús; Zoe González-Carnicero; Andrea Aguado; Frederic Jaisser; Ana M Briones; Mercedes Salaices; María J Alonso
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.